Nanotechnology and the U.S. national innovation system: Continuity and Change

نویسنده

  • David C. Mowery
چکیده

Introduction The development of nanotechnology has been spawned a large body of research on the economic and societal implications of this new technology. Much of this literature emphasizes the ways in which nanotechnology research represents a “New Wave” of public policy and inter-institutional relationships in the U.S. national innovation system, a concept that I define in greater detail below. At least two closely linked elements of novelty are cited by proponents of the “new wave” characterization (for one representative account, see Johnson, 2004): (1) Federal R&D funds are focused on economic objectives, rather than supporting fundamental research aimed at advancing knowledge; and (2) the policies adopted U.S. universities in nanotechnology research represent a new approach that has been labeled “postacademic research,” emphasizing the commercialization of discoveries through licensing of academic patents. In fact, however, these characterizations of nanotechnology research, while accurate, highlight elements that are not novel. Although the policies and institutions within which nanotechnology research now is carried out have changed in some respects, there are also important continuities in U.S. public policy and in the ways in which U.S. universities have supported innovation in nanotechnology. It seems important to focus on the elements of genuine novelty, rather than emphasizing those that are of secondary importance, and I undertake such an analysis in this brief overview.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The United States National Security Strategy under Bush and Obama: Continuity and Change

The foreign policy of states determines the way they behave in the international arena. Accurate analysis of official foreign policy documents of a country is helpful in that it shows what the international priorities of a country are at specific periods. This article reviews the U.S. National Security Strategy documents published in 2002, 2006, 2010 and 2015 from the perspective of the percept...

متن کامل

American Policy in Persian Gulf Region: Continuity or Change at the Trump Era

United States power in Persian Gulf has risen since the end of Second World War. Dividing U.S. presence in the Region into the Cold war and post-Cold war era, the principle policy in first period was narrowing the impact of Soviet Union in the Region and in latter, Access to Persian Gulf region’s oil and controlling the major threats which can disrupt the flow of oil to global energy market. Fo...

متن کامل

Biopharmaceutical Innovation System and the Influence of Policies: The Case of Taiwan (2000-2008)

This article discusses the influence of policies on the development of biopharmaceuticals. We choose the experiences of Taiwan for our empirical study and focus on the evolution between 2000 and 2008; in the period of time the country provides an interesting example for further exploration of biopharmaceutical policies. Among all the policies, the two National Programs (National Research Progra...

متن کامل

Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)

Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowled...

متن کامل

Gazelles, unicorns, and dragons battle cancer through the Nanotechnology Startup Challenge

On March 4th, 2016, Springer's Cancer Nanotechnology office promoted the launch of the Nanotechnology Startup Challenge in Cancer (NSC2 ). This innovation-development model is a partnership among our company, the Center for Advancing Innovation (CAI), MedImmune, the global biologics arm of AstraZeneca, and multiple institutes at the National Institutes of Health (NIH). NSC2 "crowdsources" talen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010